Most Recent Articles by Cindy Lampner, MSLIS
Many components of diet have been implicated as possible risk factors for RA, with varying degrees of evidence.
Therapeutic drug monitoring may be useful to help clinicians assess nonadherence in patients with SLE.
A recent systematic review found that nurse-led care is effective, acceptable, and safe in patients with rheumatoid arthritis.
Improved biomarkers are needed to monitor disease activity effectively in giant cell arteritis.
Patients with rheumatoid arthritis often use natural-product dietary supplements, but few disclose this to their healthcare providers.
More Articles by Cindy Lampner, MSLIS
Axial Psoriatic Arthritis and Ankylosing Spondylitis: Comparing Clinical, Radiologic CharacteristicsJun 20,2018
Rheumatology Advisor Articles
- One-Session Intervention for Hand OA Improved Grip Strength, Patient Satisfaction
- Exercise, TNFi Provide Differential Benefits for Cardiovascular Health in Rheumatoid Arthritis
- Improving RA Diagnosis With Use of Anti-ACPAs
- Anti-Drug Antibody Incidence Risk in RA Increases Over Time With Adalimumab, Infliximab
- MBDA Scores Reflect Response to Rituximab Treatment in Rheumatoid Arthritis
- Circadian Rhythm in Rheumatoid Arthritis: Using Chronotherapy to Improve Outcomes
- Inflammatory Arthritis and the Gut Microbiome: Do Microbes Hold the Key to New Treatments?
- Examining Insurance Complications in the Shared Decision Making Process for Rheumatoid Arthritis
- Filgotinib Safe, Effective for Treatment of Active Ankylosing Spondylitis
- FDA Fast Track Designation Granted for Investigational Osteoarthritis Treatment
- Ultrasonography in Gout: Potential Applications for Diagnosis and Patient Monitoring
- AMA Code of Medical Ethics Guides Physicians in Fighting Harmful Online Health Information
- Immunogenicity of Golimumab Validated Using Novel Anti-Drug Antibody Detection Assay
- Poor Vitamin K Status Linked to Low BMD, Increased Fracture Risk in ESRD
- Most Insured Patients Not Using Online Portals